Cancer clinical trials in the region Normandie
97 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05967689
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), CHU Caen Normandie (Caen), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire Laennec (Saint-Herblain) (and 4 more...)
Taiho Oncology
Phase 2
Breast cancer
#NCT05955170
HER2 Positive
Metastatic
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Institut Sainte Catherine (Avignon), Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Institut Curie
Phase 2
Kidney cancer
#NCT05805501
Clear cell carcinoma
Locally Advanced
Metastatic
Systemic Treatment-Naive
Systemic Treatment-Naive
1 or 2
3 or more
Immunotherapy
Targeted therapy
Immunotherapy
Targeted therapy
Centre François Baclesse (Caen )
Hoffmann-La Roche
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Hôpital Larrey (Toulouse ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Tenon AP-HP (Paris ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre François Baclesse (Caen ) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05565378
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
EGFR
ALK
Immunotherapy
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), CHU Caen Normandie (Caen), Hôpital de la Timone AP-HM (Marseille)
GlaxoSmithKline
Phase 2
Prostate cancer
#NCT05849298
Metastatic Castration-resistant
Immunotherapy
Internal Vectorised Radiotherapy (IVR)
PSMA PET Positive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Hôpital Cochin (Paris ), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), CHU Caen Normandie (Caen)
Novartis
Phase 2
Lung cancer
#NCT05403385
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
EGFR
ALK
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille) (and 4 more...)
iTeos Belgique SA
Phase 2
Lung cancer
#NCT05061550
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
EGFR
ALK
Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire de Rouen (Rouen), Hôpital Foch (Suresnes), Hôpital Sainte Musse (Toulon), Centre Hospitalier d'Avignon (Avignon)
AstraZeneca
Phase 2
Breast cancer
#NCT04985266
HER2 Negative
HR Positive
Localized
Surgery
Chemotherapy
Hormone therapy
Targeted therapy
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier de Blois (Blois) (and 16 more...)
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Lymphoma
#NCT04446962
B cell lymphoma
Primary cerebral lymphoma
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), Centre Henri Becquerel (Rouen ), Centre Hospitalier de Colmar (Colmar) (and 17 more...)
Institut Curie